- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Lazertinib, as a targeted drug for EGFR mutant non-small cell lung cancer, has clear restrictions on its use, including contraindications for s...
Ixazomib, as an oral proteasome inhibitor, has received attention from patients regarding its marketing status in China. Whether long-term use ...
Lazertinib is a targeted therapy drug for specific mutated non-small cell lung cancer, mainly exerting anti-tumor effects by inhibiting EGFR mu...
As an anti tuberculosis drug, the side effects of pretomanid mainly involve the nervous system, liver, and blood system, and different treatmen...
Pretomanid is a new type of anti tuberculosis drug, which has shown significant effect on drug-resistant tuberculosis. 1. Basic characterist...
Letermovir, as a novel anti cytomegalovirus (CMV) drug, has shown significant efficacy in preventing CMV infection after hematopoietic stem cel...
The medication duration of letermovir tablets is usually 100 days after transplantation, which is a moderate period of preventive medication. W...
Letermovir tablets are an antiviral drug mainly used to prevent cytomegalovirus (CMV) infection, particularly suitable for high-risk patients ...
The medication precautions for Ixazomib involve various aspects such as hematological toxicity, liver and kidney function monitoring, and infec...
Gilteritinib, as an FLT3 inhibitor, has significant efficacy in patients with relapsed/refractory acute myeloid leukemia (AML) carrying FLT3 mu...
